Faster global financial news!
Latigo Biotherapeutics (LTGO) completes IPO, raising nearly $350 million, with its non-opioid pain drug LTG-001 showing 50% greater relief than hydrocodone in trials.
The clinical-stage biopharmaceutical company priced its IPO at $18 per share and opened at $21. Latigo focuses on non-opioid pain medicines, and its lead asset LTG-001 for acute pain demonstrated 50% greater pain relief than hydrocodone in a 343-patient trial, positioning it for a potential opioid-free label claim. Phase 3 trials for LTG-001 are set to launch in the second half of 2026, with results expected in the second half of 2027.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
WTI crude oil rose 3.23% from its previous close, currently trading at $89.034
-
2
Gold fell 2.66% from its previous close, currently trading at $3,881.04.
-
3
The yield on the 30-year US Treasury bond rose by about 8 basis points from the previous close, currently standing at 5.44%.
-
4
The 10-year US Treasury yield rose by about 8 basis points from the previous close, currently standing at 5.08%.
-
5
Citadel Securities has poached Matthew Zimmerman from Diameter Capital Partners to head investment-grade corporate bond trading.
-
6
Watami, the Japanese restaurant group, has its founder planning to take the company private through a management buyout (MBO)
-
7
Google DeepMind has launched Gemini 4 Hydrogen, with pricing set at $1.50 and $7.50 per million tokens for input and output, respectively.
-
8
What is RCN coin? Where to trade and buy RCN coin?
-
9
Microsoft services suffer widespread outage impacting thousands of users in North America; Amazon Web Services and Google users also report disruptions
-
10
What is HNW coin? Where can HNW coin be traded and bought?
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
